Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy

被引:73
作者
Kühlkamp, V [1 ]
机构
[1] Med Klin 3, D-72076 Tubingen, Germany
关键词
D O I
10.1016/S0735-1097(01)01819-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this study, was to evaluate an implantable cardioverter-defibrillator (ICD) incorporating biventricular pacing. BACKGROUND Biventricular pacing improves the symptoms of heart failure, a frequent problem in ICD recipients. METHODS This prospective multicenter study, evaluated the safety and efficacy, of all ICD with biventricular pacing. RESULTS A total of 84 patient,, with a standard ICD indication, symptomatic heart failure, left ventricular (LV) ejection fraction <35% and a QRS duration >130 ms were included in the trial. In 81 of 84 patients the LV lead was successfully, implanted. Patients significantly improved in the 6-min hall-walk test (baseline 304 +/- 131 m, three months 397 +/- 142 m, p < 0.001), quality of life (baseline 38.9 +/- 21.2, three months 26.5 +/- 21,2, p < 0.001) and the New York Heart Association (NYHA) classification (baseline 2.8 +/- 0.6, three months 2.2 +/- 0.5). Left ventricular end-diastolic (from 79.6 +/- 13.0 mm to 73.6 +/- 12.9 mm, p = 0.002) and end-systolic (from 68.3 +/- 13.5 mm to 63.9 +/- 12.9 mm, p < 0.001) diameter decreased, and fractional shortening increased (from 16 +/- 6% to 18 +/- 6%, p = 0.018). Of the patients 26 experienced 472 episodes of spontaneous sustained ventricular tachyarrhythmias. All episodes were successfully terminated except for 16 episodes occurring in a patient with incessant ventricular tachycardia. Biventricular antitachycardia pacing was more effective than right ventricular antitachycardia pacing (p < 0.001). During follow-up (median 185 days, range 12 to 344 days) five patients died from progressive heart failure. CONCLUSIONS Incorporating biventricular pacing in an ICD is feasible and leads to all improvement of heart failure symptoms. Therefore, this, therapy, may become an option Cor patients who need ICD therapy in the presence of severe heart failure. (C) 2002 by the American College of Cardiology, Foundation.
引用
收藏
页码:790 / 797
页数:8
相关论文
共 28 条
[21]  
OLSON WH, 1998, NONPHARMACOLOGICAL T, P385
[22]   Transvenous left ventricular lead implantation with the EASYTRAK lead system:: The European experience [J].
Pürerfellner, H ;
Nesser, HJ ;
Winter, S ;
Schwierz, T ;
Hörnell, H ;
Maertens, S .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (9A) :157K-164K
[23]   ASSESSMENT OF PATIENT OUTCOME WITH THE MINNESOTA LIVING WITH HEART-FAILURE QUESTIONNAIRE - RELIABILITY AND VALIDITY DURING A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PIMOBENDAN [J].
RECTOR, TS ;
COHN, JN .
AMERICAN HEART JOURNAL, 1992, 124 (04) :1017-1025
[24]   Initial results with left ventricular pacemaker lead implantation using a preformed "peel-away" guiding sheath and "side-wire" left ventricular pacing lead [J].
Walker, S ;
Levy, T ;
Rex, S ;
Paul, V .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (06) :985-990
[25]   Preliminary results with the simultaneous use of implantable cardioverter defibrillators and permanent biventricular pacemakers: Implications for device interaction and development [J].
Walker, S ;
Levy, T ;
Rex, S ;
Brant, S ;
Paul, V .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2000, 23 (03) :365-372
[26]   Usefulness of suppression of ventricular arrhythmia by biventricular pacing in severe congestive cardiac failure [J].
Walker, S ;
Levy, TM ;
Rex, S ;
Brant, S ;
Allen, J ;
Ilsley, CJF ;
Paul, VE .
AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (02) :231-233
[27]  
Wilkoff BL, 2001, CIRCULATION, V103, P381
[28]  
Zardini M, 2000, EUR HEART J SUPPL, V2, pJ16